Development and Validation of Nomogram for Hospital Mortality in Immunocompromised Patients with Severe Pneumonia in Intensive Care Units: A Single-Center, Retrospective Cohort Study
Authors:
Open Access
- 1 January 2022
- journal article
- research article
- Published by Taylor & Francis in International Journal of General Medicine
- Vol. ume 15, 451-463
Abstract
Purpose: Risk factors and prognostic model of fatal outcomes need to be investigated for the increasing number of immunocompromised hosts (ICHs) who are hospitalized for severe pneumonia with high hospital mortality. Patients and Methods: In this single-center, retrospective study, we recruited 1,933 ICHs with severe pneumonia who were admitted to the intensive care unit (ICU) in West China hospital, Sichuan university, China between January, 2012 and December, 2018. Clinical features, laboratory findings, and fatal outcomes were collected from electronic medical records. Patients were randomly separated into a 70% training set (n=1,353) and a 30% testing set (n=580) for the development and validation of a prediction model. All data within 24 hours of ICU admission were compared between survivors and non-survivors. The risk factors were identified through LASSO and multivariate logistic regression analysis, and then used to develop a predicting nomogram. The nomogram for predicting hospital mortality of ICHs with severe pneumonia in the ICU was validated by C-index, AUC (area under the curve), calibration curve, and Decision Curve Analysis (DCA). Results: Eight risk factors, including age, fever, dyspnea, chronic renal disease, platelet counts, neutrophil counts, PaO2/FiO2 ratio, and the requirement for vasopressors, were adopted in a nomogram for predicting hospital mortality. The nomogram had great predicting accuracy with a C-index of 0.819 (95% CI=0.795– 0.842) in the training set, and a C-index of 0.819 (95% CI=0.783– 0.855) in the testing set for hospital mortality. Additionally, the nomogram had well-fitted calibration curves. DCA demonstrated that the nomogram was clinically beneficial. Conclusion: This study developed a novel nomogram for predicting hospital mortality of ICHs with severe pneumonia in the ICU. Validation showed good discriminatory ability and calibration, indicating that the nomogram was expected to be a superior predictive tool for doctors to identify risk factors and predict mortality, and might be generally applied in clinical practice after more external validations.Keywords
This publication has 28 references indexed in Scilit:
- Nomograms in oncology: more than meets the eyeThe Lancet Oncology, 2015
- The past, present, and future of cancer incidence in the United States: 1975 through 2020Cancer, 2015
- Immunosuppression Associated With Novel Chemotherapy Agents and Monoclonal AntibodiesClinical Infectious Diseases, 2014
- Clinical immune‐monitoring strategies for predicting infection risk in solid organ transplantationClinical & Translational Immunology, 2014
- Survival in neutropenic patients with severe sepsis or septic shock*Critical Care Medicine, 2012
- Clinical review: Fever in septic ICU patients - friend or foe?Critical Care, 2011
- Validation and comparison of SCAP as a predictive score for identifying low-risk patients in community-acquired pneumoniaJournal of Infection, 2010
- Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in AdultsClinical Infectious Diseases, 2007
- Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation studyThorax, 2003
- A Prediction Rule to Identify Low-Risk Patients with Community-Acquired PneumoniaNew England Journal of Medicine, 1997